drugset / Trial / NCT00100828
Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer
Phase 2
Terminated
6 enrolled
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well irinotecan works in treating patients with metastatic or inoperable thyroid cancer.
Timeline
- Start
- 2004-11
- Primary completion
- 2008-11
- Completion
- 2008-11
Outcome
Outcome not reported
Stopped: “Closed due to early stopping rule”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | — | Intravenous |